Pharmacogenomic landscape of Indian population using whole genomes S Sahana, RC Bhoyar, A Sivadas, A Jain, M Imran, M Rophina, ... Clinical and Translational Science 15 (4), 866-877, 2022 | 14 | 2022 |
Pharmacogenomic landscape of COVID-19 therapies from Indian population genomes S Sahana, A Sivadas, M Mangla, A Jain, RC Bhoyar, K Pandhare, ... Pharmacogenomics 22 (10), 603-618, 2021 | 7 | 2021 |
Landscape of pharmacogenetic variants associated with non-insulin antidiabetic drugs in the Indian population A Sivadas, S Sahana, B Jolly, RC Bhoyar, A Jain, D Sharma, M Imran, ... BMJ Open Diabetes Research and Care 12 (2), e003769, 2024 | 3 | 2024 |
Genetic epidemiology of monogenic dyslipidemia and statin-associated adverse drug phenotypes in Indian population from whole-genomes of 1029 self-declared healthy individuals M Imran, RC Bhoyar, A Jain, S Sahana, M Rophina, VR Arvinden, ... Human Gene 39, 201252, 2024 | 3 | 2024 |
Development of an In Silico Platform (TRIPinRNA) for the Identification of Novel RNA Intramolecular Triple Helices and Their Validation Using Biophysical Techniques I Rakheja, V Bharti, S Sahana, PK Das, G Ranjan, A Kumar, N Jain, ... Biochemistry, 2024 | | 2024 |
The genomic landscape of CYP2D6 variation in the Indian population A Sivadas, S Rathore, S Sahana, B Jolly, RC Bhoyar, A Jain, D Sharma, ... Pharmacogenomics 25 (3), 147-160, 2024 | | 2024 |